Vaccinating sons against HPV: results from a U.S. national survey of parents.

ABSTRACT:

Purpose

The quadrivalent HPV vaccination was approved for use in males ages 9 to 26 in 2009 and recommended for routine administration in 2011. The purpose of this study was to uncover predictable commonalities amongst parents who chose to vaccinate their 11-17 year old sons against HPV.

Methods

We compiled data from a U.S. national sample of 779 parents with sons 11-17 years old using a web-based survey to gather information about behavioral and sociodemographic factors which predicted receipt of 1 or more HPV vaccine doses based on parental report. Predictors were first modeled individually for univariable associations. Significant predictors (p<0.10) were combined in a multivariable model.

Results

In the adjusted model, independent predictors included receipt of fl

SUBMITTER: Taylor JL 

PROVIDER: S-EPMC4277268 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature